Search Results 1081-1090 of 5515 for 搜索引擎原理咨询邮箱：lgooxc@hotmail.com
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...
This study consist of two parts (Part 1 and Part 2). The purpose of Part 1 is to evaluate the way the body absorbs, distributes and removes the drug LCZ696.
The primary purpose of this study is to evaluate the progression free survival (PFS) of advanced pancreatic cancer patients with germline BRCA1 or BRCA2 ...
Mayo Clinic researcher Gregory A. Nuttall, M.D., studies blood management in patients who have undergone cardiac surgery with the aim to improve patient ...
About this study. The investigators hypothesize that intensive acid suppression with a long acting high potency proton pump inhibitor (dexlansoprazole) will ...
Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions ...
Mayo Clinic pathologist Aziza Nassar, M.D., M.P.H., M.B.A., researches benign breast disease and sclerosing adenosis to help predict breast cancer risk.
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.